(Loss).
For the years ended December 31, 2024, 2023 and 2022, we incurred pre-tax separation expense of $
492
million, $
692
million and  $
625
million, and paid $
800
million, $
820
million and $
134
million in cash, respectively. We recognized $
349
million, $
113
million and  $
4
million of net tax benefits for the years ended December 31, 2024, 2023 and 2022, respectively, including deferred tax benefits associated with state tax attributes and the tax benefit of losses on separation-related entity restructuring.
The pre-tax separation costs specifically identifiable to GE HealthCare and GE Vernova are now reflected in discontinued operations. For the year ended December 31, 2024, we recognized $
15
million in pre-tax income, $
3
million of net tax expense, and spent $
16
million in cash, respectively, related to GE HealthCare. In addition, we recognized pre-tax separation costs of $
96
million, recognized $
20
million of net tax benefit and spent $
199
million in cash, respectively, related to GE Vernova.
For the year ended December 31, 2023, we incurred $
22
million in pre-tax costs, recognized $
5
million of net tax benefit and spent $
182
million in cash, respectively, related to GE HealthCare. Related to GE Vernova, we incurred $
286
million pre-tax separation costs, recognized $
86
million of net tax benefit and spent $
239
million in cash for the year ended December 31, 2023.
For the year ended December 31, 2022, we incurred $
258
million in pre-tax costs, recognized $
54
million of net tax benefit and spent  $
103
million in cash, respectively, related to GE HealthCare. Related to GE Vernova, we incurred $
90
million pre-tax separation costs, recognized $
19
million of net tax benefit and spent $
24
million in cash for the year ended December 31, 2022.
NOTE 21.
FAIR VALUE MEASUREMENTS
Our assets and liabilities measured at fair value on a recurring basis include debt securities mainly supporting obligations to annuitants and policyholders in our run-off insurance operations, our equity interests in AerCap and derivatives.
2024 FORM 10-K
69
(a)
Included $
1,627
million of U.S. corporate debt securities, $
1,935
million of Mortgage and asset-backed debt securities, and the $
982
million AerCap note at December 31, 2024. Included $
3,873
million of U.S. corporate debt securities, $
1,491
million of Mortgage and asset-backed debt securities, and the $
944
million AerCap note at December 31, 2023.
(b)
The netting of derivative receivables and payables is permitted when a legally enforceable master netting agreement exists. Amounts include fair value adjustments related to our own and counterparty non-performance risk.
(c)
Included investment securities in our run-off insurance operations of $
37,352
million and $
37,592
million as of December 31, 2024 and 2023, respectively, which are Level 2 and 3.  See Notes 3 and 22 for further information on the composition of our investment securities and derivative portfolios.
(d)
Primarily